Higher daily step counts are associated with fewer depressive symptoms in adults, according to a systematic review and meta-analysis published online online Dec. 16 in JAMA Network Open.

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The number of union petitions with physicians in the bargaining units filed and certified increased in 2023 to May 2024, according to a research letter published online Dec. 18 in the Journal of the ...